Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility.

about

The value of genetic testing: beyond clinical utility.Response to commentaries: Slowing down the rush to translation in personal genomics.Medicine, market and communication: ethical considerations in regard to persuasive communication in direct-to-consumer genetic testing services.

P2860

Q43637974-AB34EB55-A716-4892-A835-DEEDBEED5E54 Q52301803-429A06A4-594B-4DD0-AA7D-60469C5B4DE7 Q55344765-9E604793-BFE5-4B0E-BA3F-4CA82265F719

P2860

Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility.

Item

http://www.wikidata.org/entity/Q52301800

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Debating the clinical utility ...... for addiction susceptibility.

@en

Debating the clinical utility ...... for addiction susceptibility.

@nl

type

Item

label

Debating the clinical utility ...... for addiction susceptibility.

@en

Debating the clinical utility ...... for addiction susceptibility.

@nl

prefLabel

Debating the clinical utility ...... for addiction susceptibility.

@en

Debating the clinical utility ...... for addiction susceptibility.

@nl

P1476

Debating the clinical utility ...... for addiction susceptibility.

@en

P2093

Lidewij Henneman

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours

Debating clinical utility

Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes.

Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market.

Direct-to-consumer personalized genomic testing.

Legislation on direct-to-consumer genetic testing in seven European countries.

A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions

Interest of adolescents in genetic testing for nicotine addiction susceptibility.

Being at risk for cardiovascular disease: perceptions and preventive behavior in people with and without a known genetic predisposition.

Evaluating the utility of personal genomic information.

P304

2076-2077

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1360-0443.2012.03939.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Pascal Borry

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233736739

http://www.w3.org/2001/XMLSchema#string

P698

23167641

http://www.w3.org/2001/XMLSchema#string

Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility.

about

P2860

P2860

Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698